Citius Pharmaceuticals Inc vs Fox Corp Class A — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Fox Corp Class A trades at $61.87 (market cap $24.58B). The key difference: Fox Corp Class A is far larger — about 1228.4× Citius Pharmaceuticals Inc's market cap, and Fox Corp Class A pays a 0.93% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTXR | FOXA | |
|---|---|---|
Market Cap | $20.01M | $24.58B |
Sector | Health | Media |
52-Week High | $1.82 | $76.11 |
52-Week Low | $0.48 | $48.79 |
Enterprise Value | $16.23M | $27.94B |
Dividend Yield | — | 0.93% |
Trailing returns across standard periods
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →